Transforming chemotherapy for better patient outcomes, Jack Bailey, CEO, G1 Therapeutics
Synopsis: Jack Bailey is the CEO of G1 Therapeutics, a commercial-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the live...
22 Feb 202331min
Personalized regenerative medicines, Nabiha Saklayen, PhD, Co-Founder & CEO, Cellino
Synopsis: Nabiha Saklayen, PhD, is the Co-Founder and CEO of Cellino Biotech, a company working to democratize access to personalized stem cell-based therapies for patients at scale. Nabiha joins hos...
15 Feb 202329min
Engaging the immune system against disease, Andrew Allen, Co-Founder, President & CEO, Gritstone bio
Synopsis: Andrew Allen is the Co-Founder, President and CEO of Gritstone bio, a clinical-stage biotech company developing groundbreaking immunotherapies for cancers and infectious diseases such as C...
8 Feb 202347min
Novel approach to targeted protein degradation, Nicki Thompson, CEO, Amphista Therapeutics
Synopsis: Nicki Thompson is the CEO of Amphista Therapeutics, a company identifying and advancing novel approaches in targeted protein degradation to develop a new generation of innovative therapies....
1 Feb 202333min
Envisioning people focused clinical trials, Michael Rosenblatt, VP of Clinical Operations, Roche
Disclaimer: Anything that is express in the following conversation are Michael's views and not necessarily those of Roche / Genentech. Synopsis: Michael Rosenblatt is the Vice President of Clinical...
25 Jan 202326min
Power of RNA to restore healthy gene expression, Josh Mandel-Brehm, President & CEO, CAMP4 Tx
Synopsis: Josh Mandel-Brehm is the President and CEO of CAMP4 Therapeutics, a company pioneering mRNA amplification by using programmable ASO therapeutics to control gene expression. He joins host Ra...
18 Jan 202329min
JPM23 Special: Rare diseases, Eslie Dennis, Kyowa Kirin, Arthur Suckow, DTx, & James Mackay, Aristea
Synopsis: This special episode features a panel discussion with three biotech leaders about drug development for rare diseases. James Mackay, Ph.D., is the Founder, President and CEO of Aristea Ther...
11 Jan 202336min
JPM23 Special: Redefining cystic fibrosis treatment, Mike Cloonan, Pres. & CEO, Sionna Tx
Synopsis: Mike Cloonan is the President and CEO of Sionna Therapeutics, a life sciences company dedicated to developing therapies for people living with cystic fibrosis. They are developing first-in...
10 Jan 202325min
